AstraZeneca Looks To Block Generic Pulmicort
AstraZeneca PLC on Monday asked a New Jersey federal court to block the manufacture and distribution of a generic version of its Pulmicort Respules asthma medication for children by Breath Ltd....To view the full article, register now.
Already a subscriber? Click here to view full article